Rachel Rosovsky /LinkedIn
Oct 31, 2025, 02:06
Rachel Rosovsky Presents STORM-PE RCT Results at VIVA 2025
Rachel Rosovsky, Hematologist at Massachusetts General Hospital, posted on LinkedIn:
”The first-and only-RCT demonstrating the efficacy of anticoagulation (AC) for the treatment of PE was conducted in 1960 and included 73 patients. Join us at VIVA 2025 to see how far we’ve come. On behalf of the entire STORM-PE team and in collaboration with PERT Consortium, I will be presenting the clinical and functional outcomes of the first RCT comparing mechanical thrombectomy plus AC versus AC alone in patients with acute intermediate–high-risk PE.
Robert Lookstein, Prof.Dr.Stavros Konstantinides, Ido Weinberg, John Moriarty, Sahil Parikh, Suhail Dohad, Richard Channick, Richard Davis, The PERT Consortium®”
Stay updated with Hemostasis Today.
Anticoagulation
Deep venous thrombosis
DVT
Health
Hematology
Hemostasis
Hemostasis Today
Ido Weinberg
John Moriarty
Medicine
PERT Consortium
Prof.Dr.Stavros Konstantinides
Pulmonary embolism
Rachel Rosovsky
Richard Channick
Richard Davis
Robert Lookstein
Sahil Parikh
STORM-PE
Suhail Dohad
thrombosis
Venous Thrombosis
VIVA 2025
-
Nov 8, 2026, 16:54James P. Crowley: DOAC Testing Under 50 ng/mL Safely Expedites Urgent Hip Fracture Surgery
-
Nov 8, 2026, 16:21Alessandra Bosch: Women and Girls With Bleeding Disorders and the DACH Registries at HHS 2026
-
Nov 8, 2026, 15:0310 Posts Not to Miss This Week
-
Nov 8, 2026, 14:55Andra T.: Antiphospholipid Syndrome and Its Thrombotic Risks
-
Nov 8, 2026, 14:06Shayan Mohammadmoradi: ZEUS Trial-Inflammation Reduction Without Fewer Cardiovascular Events
-
Nov 8, 2026, 14:05Kausik Ray: Plaque-Guided Care for Better Coronary Outcomes
-
Nov 8, 2026, 14:05Athira Elssa Johnson: Understanding Coronary Thrombosis and Its Risks
-
Nov 8, 2026, 14:04Sanjiv Beri: Blood Type Compatibility and the Balance of Giving and Receiving
-
Nov 8, 2026, 14:02Gabriela Hobbs: Recognizing Outstanding Abstract Achievements-ASH 2026